NCT02956785View on ClinicalTrials.gov

What After the First Propess

PHASE2TerminatedINTERVENTIONAL

Enrollment

85

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

November 30, 2022

Study Completion Date

November 30, 2022

Conditions

Induction of Labor

Interventions

DRUG

10 mg Dinoprostone; CTS, UK

DRUG

3 mg Dinoprostone vaginal tablet; Pfizer, UK

DRUG

Aquacryl hydrogel rod; HPSRx Enterprises, USA

Trial Locations (1)

WS2 9PS

Walsall Healthcare NHS Trust, Walsall

Sponsors

Collaborators (1)

Medicem International

All Listed Sponsors

collaborator

Medicem International

UNKNOWN

collaborator

Walsall Healthcare NHS Trust

OTHER

lead

South Warwickshire NHS Foundation Trust

OTHER